Exploring the role of framework mutations in enabling breadth of a cross-reactive antibody (CR3022) against the SARS-CoV-2 RBD and its variants of concern

References

• Zhao, F. (2021). Broadening a SARS-CoV-1 neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution. bioRxiv, https://doi.org/10.1101/2021.05.29.443900
   Google Scholar
• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Ahamad, S., Hema, K., & Gupta, D. (2021). Structural stability predictions and molecular dynamics simulations of RBD and HR1 mutations associated with SARS-CoV-2 spike glycoprotein. Journal of Biomolecular Structure and Dynamics, https://doi.org/10.1080/07391102.2021.1889671
   Google Scholar
• Ahamad, S., Kanipakam, H. & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. J. Biomol. Struct. Dyn, 40, 1.
   Google Scholar
• Barnes, C. O., Jette, C. A., Abernathy, M. E., Dam, K.-M A., Esswein, S. R., Gristick, H. B., Malyutin, A. G., Sharaf, N. G., Huey-Tubman, K. E., Lee, Y. E., Robbiani, D. F., Nussenzweig, M. C., West, A. P., & Bjorkman, P. J. (2020). SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature, 588(7839), 682–687. 2020 588 https://doi.org/10.1038/s41586-020-2852-1
   PubMed Web of Science ®Google Scholar
• Bates, T. A., Weinstein, J. B., Leier, H. C., Messer, W. B., & Tafesse, F. G. (2021). Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2. Cell Rep., 34(7), 108737.
   Google Scholar
• Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1–3), 43–56. https://doi.org/10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Bonvin Lab. (2020). HADDOCK2.4 antibody - Antigen tutorial using PDB-tools webserver. https://www.bonvinlab.org/education/HADDOCK24/HADDOCK24-antibody-antigen/.
   Google Scholar
• CDC. (2021). SARS-CoV-2 variants of concern. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html.
   Google Scholar
• Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010). MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallographica Section D, Biological Crystallography, 66(Pt 1), 12–21. https://doi.org/10.1107/S0907444909042073
   PubMed Web of Science ®Google Scholar
• Cui, J., Li, F., & Shi, Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17(3), 181–192. https://doi.org/10.1038/s41579-018-0118-9
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An overview of their replication and pathogenesis. In Coronaviruses: Methods and protocols (pp. 1–23). Springer. https://doi.org/10.1007/978-1-4939-2438-7_1
   Google Scholar
• Fraley, E., LeMaster, C., Banerjee, D., Khanal, S., Selvarangan, R., & Bradley, T. (2021). Cross-reactive antibody immunity against SARS-CoV-2 in children and adults. Cellular & Molecular Immunology, 18(7), 1826–1828. 2021 18 https://doi.org/10.1038/s41423-021-00700-0
   PubMed Web of Science ®Google Scholar
• Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., Hilton, S. K., Huddleston, J., Eguia, R., Crawford, K. H. D., Dingens, A. S., Nargi, R. S., Sutton, R. E., Suryadevara, N., Rothlauf, P. W., Liu, Z., Whelan, S. P. J., Carnahan, R. H., Crowe, J. E., & Bloom, J. D. (2021). Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host & Microbe, 29(1), 44–57.e9. https://doi.org/10.1016/j.chom.2020.11.007
   PubMed Web of Science ®Google Scholar
• Guex, N., & Peitsch, M. C. (1997). SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis, 18(15), 2714–2723. https://doi.org/10.1002/elps.1150181505
   PubMed Web of Science ®Google Scholar
• Heo, L., Park, H., & Seok, C. (2013). GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Research, 41
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Huang, J., Rauscher, S., Nawrocki, G., Ran, T., Feig, M., de Groot, B. L., Grubmüller, H., & MacKerell, A. D. (2017). CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nature Methods, 14(1), 71–73. https://doi.org/10.1038/nmeth.4067
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM. Journal of Computational Chemistry, 29(11), 1859–1865.
   PubMed Web of Science ®Google Scholar
• Johnson, C. R., Yu, W., & Murtaugh, M. P. (2007). Cross-reactive antibody responses to nsp1 and nsp2 of porcine reproductive and respiratory syndrome virus. The Journal of General Virology, 88(Pt 4), 1184–1195. https://doi.org/10.1099/vir.0.82587-0
   PubMedGoogle Scholar
• Klein, F., Diskin, R., Scheid, J. F., Gaebler, C., Mouquet, H., Georgiev, I. S., Pancera, M., Zhou, T., Incesu, R.-B., Fu, B. Z., Gnanapragasam, P. N. P., Oliveira, T. Y., Seaman, M. S., Kwong, P. D., Bjorkman, P. J., & Nussenzweig, M. C. (2013). Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell, 153(1), 126–138. https://doi.org/10.1016/j.cell.2013.03.018
   PubMed Web of Science ®Google Scholar
• Krawczyk, K., Liu, X., Baker, T., Shi, J., & Deane, C. M. (2014). Improving B-cell epitope prediction and its application to global antibody-antigen docking. Bioinformatics (Oxford, England), 30(16), 2288–2294. https://doi.org/10.1093/bioinformatics/btu190
   PubMed Web of Science ®Google Scholar
• Letunic, I., & Bork, P. (2021). Interactive Tree Of Life (iTOL) v5: An online tool for phylogenetic tree display and annotation. Nucleic Acids Research, 49(W1), W293–W296. https://doi.org/10.1093/nar/gkab301
   PubMed Web of Science ®Google Scholar
• Liberis, E., Veličković, P., Sormanni, P., Vendruscolo, M., & Liò, P. (2018). Parapred: Antibody paratope prediction using convolutional and recurrent neural networks. Bioinformatics (Oxford, England), 34(17), 2944–2950. https://doi.org/10.1093/bioinformatics/bty305
   PubMed Web of Science ®Google Scholar
• Masters, P. S. (2006). The Molecular Biology of Coronaviruses. Advances in Virus Research, 65, 193–292.
   Web of Science ®Google Scholar
• Meireles, L. M. C., D�Mling, A. S., & Camacho, C. J. (2010). ANCHOR: A web server and database for analysis of protein-protein interaction binding pockets for drug discovery. Nucleic Acids Research, 38(Web Server issue), W407–W411. https://doi.org/10.1093/nar/gkq502
   PubMedGoogle Scholar
• Meyers, L. M., Gutiérrez, A. H., Boyle, C. M., Terry, F., McGonnigal, B. G., Salazar, A., Princiotta, M. F., Martin, W. D., De Groot, A. S., & Moise, L. (2021). Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation. Npj Vaccines, 6(1), 1–14. https://doi.org/10.1038/s41541-021-00331-6
   PubMed Web of Science ®Google Scholar
• Mortola, E., & Roy, P. (2004). Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Letters, 576(1–2), 174–178. https://doi.org/10.1016/j.febslet.2004.09.009
   PubMed Web of Science ®Google Scholar
• Narayanan, K., Ramirez, S. I., Lokugamage, K. G., & Makino, S. (2015). Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression. Virus Research, 202, 89–100. https://doi.org/10.1016/j.virusres.2014.11.019
   PubMed Web of Science ®Google Scholar
• Nelson-Sathi, S., P. K. Umasankar, E. Sreekumar, R. Radhakrishnan Nair, Iype Joseph, Sai Ravi Chandra Nori, Jamiema Sara Philip, Roshny Prasad, K. V. Navyasree, Shikha Ramesh, Heera Pillai, Sanu Ghosh, T. R. Santosh Kumar & M. Radhakrishna Pillai. (2022). Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction. BMC Mol. Cell Biol., 23, 1–12.
   Google Scholar
• Niu, L., Wittrock, K. N., Clabaugh, G. C., Srivastava, V., & Cho, M. W. (2021). A Structural landscape of neutralizing antibodies against SARS-CoV-2 receptor binding domain. Frontiers in Immunology, 12, 1427. https://doi.org/10.3389/fimmu.2021.647934
   Web of Science ®Google Scholar
• Ovchinnikov, V., Louveau, J. E., Barton, J. P., Karplus, M., & Chakraborty, A. K. (2018). Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies. eLife, 7, e33038. https://doi.org/10.7554/eLife.33038
   Google Scholar
• Peiris, J. S. M., Chu, C. M., Cheng, V. C. C., Chan, K. S., Hung, I. F. N., Poon, L. L. M., Law, K. I., Tang, B. S. F., Hon, T. Y. W., Chan, C. S., Chan, K. H., Ng, J. S. C., Zheng, B. J., Ng, W. L., Lai, R. W. M., Guan, Y., & Yuen, K. Y. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. The Lancet, 361(9371), 1767–1772. https://doi.org/10.1016/S0140-6736(03)13412-5
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021). UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Science : A Publication of the Protein Society, 30(1), 70–82. https://doi.org/10.1002/pro.3943
   PubMed Web of Science ®Google Scholar
• Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., Peter, A., Guarino, B., Spreafico, R., Cameroni, E., Case, J. B., Chen, R. E., Havenar-Daughton, C., Snell, G., Telenti, A., … Corti, D. (2020). Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature, 583(7815), 290–295. 2020 583 https://doi.org/10.1038/s41586-020-2349-y
   PubMed Web of Science ®Google Scholar
• Public Health England. (2021). SARS-CoV-2 variants of concern and variants under investigation in England. Sage 1–50.
   Google Scholar
• Safavi, A., Kefayat, A., Mahdevar, E., Abiri, A., & Ghahremani, F. (2020). Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine, 38(48), 7612–7628. https://doi.org/10.1016/j.vaccine.2020.10.016
   PubMed Web of Science ®Google Scholar
• Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., & Hurley, A. (2011). Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science, 333, 1633–1637.
   PubMed Web of Science ®Google Scholar
• Schritt, D., Li, S., Rozewicki, J., Katoh, K., Yamashita, K., Volkmuth, W., Cavet, G., & Standley, D. M. (2019). Repertoire builder: High-throughput structural modeling of B and T cell receptors. Molecular Systems Design & Engineering, 4(4), 761–768. https://doi.org/10.1039/C9ME00020H
   Web of Science ®Google Scholar
• Shah, M., Ahmad, B., Choi, S., & Woo, H. G. (2020). Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization. Computational and Structural Biotechnology Journal, 18, 3402–3414. https://doi.org/10.1016/j.csbj.2020.11.002
   PubMed Web of Science ®Google Scholar
• Simonich, C. A. (2019). Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage. Nature Communications, 10(1), 1–12.
   PubMedGoogle Scholar
• Sumbalova, L., Stourac, J., Martinek, T., Bednar, D., & Damborsky, J. (2018). HotSpot Wizard 3.0: Web server for automated design of mutations and smart libraries based on sequence input information. Nucleic Acids Research, 46(W1), W356–W362. https://doi.org/10.1093/nar/gky417
   PubMed Web of Science ®Google Scholar
• Tan, G. S., Leon, P. E., Albrecht, R. A., Margine, I., Hirsh, A., Bahl, J., & Krammer, F. (2016). Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection. PLoS Pathogens, 12(4), e1005578. https://doi.org/10.1371/journal.ppat.1005578
   PubMed Web of Science ®Google Scholar
• Tea, F., Ospina Stella, A., Aggarwal, A., Ross Darley, D., Pilli, D., Vitale, D., Merheb, V., Lee, F. X. Z., Cunningham, P., Walker, G. J., Fichter, C., Brown, D. A., Rawlinson, W. D., Isaacs, S. R., Mathivanan, V., Hoffmann, M., Pöhlman, S., Mazigi, O., Christ, D., … Turville, S. G. (2021). SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants. PLoS Medicine, 18(7), e1003656. https://doi.org/10.1371/journal.pmed.1003656
   PubMed Web of Science ®Google Scholar
• Ter Meulen, J., van den Brink, E. N., Poon, L. L. M., Marissen, W. E., Leung, C. S. W., Cox, F., Cheung, C. Y., Bakker, A. Q., Bogaards, J. A., van Deventer, E., Preiser, W., Doerr, H. W., Chow, V. T., de Kruif, J., Peiris, J. S. M., & Goudsmit, J. (2006). Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants. PLoS Medicine, 3(7), e237. https://doi.org/10.1371/journal.pmed.0030237
   PubMed Web of Science ®Google Scholar
• Tsumoto, K., Ogasahara, K., Ueda, Y., Watanabe, K., Yutani, K., & Kumagai, I. (1996). Role of Salt Bridge Formation in Antigen-Antibody interaction. Entropic contribution to the complex between hen egg white lysozyme and its monoclonal antibody HyHEL10*. The Journal of Biological Chemistry, 271(51), 32612–32616. https://doi.org/10.1074/jbc.271.51.32612
   PubMed Web of Science ®Google Scholar
• Wang, E., Sun, H., Wang, J., Wang, Z., Liu, H., Zhang, J. Z. H., & Hou, T. (2019). End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design. Chemical Reviews, 119(16), 9478–9508. https://doi.org/10.1021/acs.chemrev.9b00055
   PubMed Web of Science ®Google Scholar
• Weng, G., Wang, E., Wang, Z., Liu, H., Zhu, F., Li, D., & Hou, T. (2019). HawkDock: A web server to predict and analyze the protein-protein complex based on computational docking and MM/GBSA. Nucleic Acids Research, 47(W1), W322–W330. https://doi.org/10.1093/nar/gkz397
   PubMed Web of Science ®Google Scholar
• Wintjens, R., Bifani, A. M., & Bifani, P. (2020). Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein. NPJ Vaccines, 5(1), 1–8. https://doi.org/10.1038/s41541-020-00237-9
   PubMed Web of Science ®Google Scholar
• Yuan, M. (2022). Structural basis of a shared antibody response to SARS-CoV-2. http://science.sciencemag.org/.
   Google Scholar
• Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C D., So, R. T. Y., Lv, H., Mok, C. K. P., & Wilson, I. A. (2020). A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science (New York, N.Y.), 368(6491), 630–633. https://doi.org/10.1126/science.abb7269
   PubMed Web of Science ®Google Scholar
• Zhou, J. O., Zaidi, H. A., Ton, T., & Fera, D. (2020). The effects of framework mutations at the variable domain interface on antibody affinity maturation in an HIV-1 broadly neutralizing antibody lineage. Frontiers in Immunology, 11, 1529. https://doi.org/10.3389/fimmu.2020.01529
   PubMed Web of Science ®Google Scholar